FDA Approves Larger-Capacity Insulin Pump

(t:flex, courtesy of Tandem Diabetes Care)

On January 9, 2015, the U.S. Food and Drug Administration (FDA) approved the t:flex insulin pump for people with diabetes ages 12 and over who require insulin.


With a 480-unit reservoir, the pump will have the largest capacity of any insulin pump available in the United States, according to manufacturer Tandem Diabetes Care. It is designed for people who need more than 100 units of U-100 insulin per day, such as teenagers with Type 1 diabetes and many people with Type 2, providing the advantages of pump therapy without necessitating the frequent reservoir changes required by standard 200- or 300-unit pumps.

Like its sister device, the t:slim, this pump uses “Micro-Delivery technology” to facilitate accurate insulin dosing and features a color touch screen.

“In recognizing that one size does not fit all, the t:flex pump was developed using Tandem’s proprietary technology platform to bring t:slim’s benefits to people with greater insulin needs,” noted Kim Blickenstaff, president and CEO of Tandem Diabetes Care.

The t:flex is expected to hit the U.S. market in the second quarter of 2015.

For more information about the t:slim insulin pump, and to sign up to be notified when the pump is available for order, see the Tandem Diabetes Care website.